Osteopenia Completed Phase 4 Trials for Ibandronate (DB00710)

Also known as: Osteopaenia / Bone loss

IndicationStatusPhase
DBCOND0015922 (Osteopenia)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01287533Efficacy of Monthly Ibandronate in Women With RA and Reduced Bone Mineral Density Receiving Long-term SteroidsPrevention